Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Mantle Cell Lymphoma, Venetoclax

Konstantinos Lontos

MD

🏢UPMC Hillman Cancer Center🌐USA

Assistant Professor of Hematology-Oncology

28
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Konstantinos Lontos specializes in the use of venetoclax-based combinations for mantle cell lymphoma, investigating BCL2 dependency and synergy with BTK inhibitors. His clinical research focuses on venetoclax plus ibrutinib doublets in both frontline and relapsed settings. He has contributed to studies identifying predictors of venetoclax response and resistance in MCL.

Share:

🧪Research Fields 研究领域

venetoclax MCL
BCL2 in lymphoma
combination regimens MCL
BTK venetoclax
MCL relapsed

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Konstantinos Lontos 的研究动态

Follow Konstantinos Lontos's research updates

留下邮箱,当我们发布与 Konstantinos Lontos(UPMC Hillman Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment